The burden of disease attributable to cannabis use in Canada in 2012
Addiction2015Vol. 111(4), pp. 653–662
Citations Over TimeTop 10% of 2015 papers
Sameer Imtiaz, Kevin D. Shield, Michael Roerecke, Joyce Cheng, Svetlana Popova, Paul Kurdyak, Benedikt Fischer, Jürgen Rehm
Abstract
The cannabis-attributable burden of disease in Canada in 2012 included 55,813 years of life lost due to disability, caused mainly by cannabis use disorders. Although the cannabis-attributable burden of disease was substantial, it was much lower compared with other commonly used legal and illegal substances. Moreover, the evidence base for cannabis-attributable harms was smaller.
Related Papers
- → The burden of disease in Germany at the national and regional level—results in terms of disability-adjusted life years (DALY) from the BURDEN 2020 study(2022)37 cited
- → The prevalence and burden of mental and substance use disorders in Australia: Findings from the Global Burden of Disease Study 2015(2018)59 cited
- → Burden of diabetes mellitus attributable to demographic levels in Qatar: An emerging public health problem(2014)29 cited
- → THE PREVALENCE AND BURDEN OF MENTAL AND SUBSTANCE USE DISORDERS IN ROMANIA: FINDINGS FROM THE GLOBAL BURDEN OF DISEASE STUDY 2016(2019)10 cited